tiprankstipranks
Trending News
More News >
Immunicum AB (SE:IMMU)
:IMMU
Sweden Market

Immunicum AB (IMMU) Financial Statements

Compare
3 Followers

Immunicum AB Financial Overview

Immunicum AB's market cap is currently kr257.18M. The company's EPS TTM is kr-0.74; its P/E ratio is -1.89; Immunicum AB is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 0.00kr 28.49Mkr 3.00Mkr 6.00K
Gross Profitkr 0.00kr -6.52Mkr 28.49Mkr -1.85Mkr -1.84M
Operating Incomekr -120.26Mkr -135.15Mkr -100.65Mkr -133.68Mkr -130.10M
EBITDAkr -120.26Mkr -120.66Mkr -97.85Mkr -128.67Mkr -128.28M
Net Incomekr -113.26Mkr -128.40Mkr -101.62Mkr -136.99Mkr -136.69M
Balance Sheet
Cash & Short-Term Investmentskr 64.66Mkr 101.91Mkr 120.78Mkr 41.85Mkr 155.31M
Total Assetskr 628.32Mkr 696.36Mkr 755.95Mkr 620.39Mkr 720.98M
Total Debtkr 33.28Mkr 22.71Mkr 24.49Mkr 78.16Mkr 36.98M
Net Debtkr -31.37Mkr -79.20Mkr -96.29Mkr 36.31Mkr -118.34M
Total Liabilitieskr 43.26Mkr 51.22Mkr 51.23Mkr 105.95Mkr 64.24M
Stockholders' Equitykr 585.07Mkr 645.15Mkr 704.73Mkr 514.44Mkr 656.74M
Cash Flow
Free Cash Flowkr -81.84Mkr -81.51Mkr -164.58Mkr -121.43Mkr -139.39M
Operating Cash Flowkr -81.53Mkr -79.67Mkr -162.76Mkr -109.33Mkr -138.03M
Investing Cash Flowkr -734.00Kkr -1.58Mkr -442.00Kkr -12.32Mkr -1.36M
Financing Cash Flowkr 45.18Mkr 61.52Mkr 242.10Mkr 8.19Mkr 127.03M
Currency in SEK

Immunicum AB Earnings and Revenue History

Immunicum AB Debt to Assets

Immunicum AB Cash Flow

Immunicum AB Forecast EPS vs Actual EPS